Rajthanee Hospital PCL (BKK:RJH)
Thailand
· Delayed Price · Currency is THB 12.75
-0.19 (-1.50%)
At close: Mar 9, 2026
Rajthanee Hospital PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 2,741 | 2,739 | 2,348 | 3,365 | 3,118 | Upgrade
|
| Other Revenue | 28.9 | 26.09 | 27.54 | 26.15 | 24.28 | Upgrade
|
| Revenue | 2,770 | 2,765 | 2,375 | 3,392 | 3,142 | Upgrade
|
| Revenue Growth (YoY) | 0.20% | 16.39% | -29.96% | 7.94% | 67.35% | Upgrade
|
| Cost of Revenue | 2,073 | 1,897 | 1,618 | 1,848 | 1,684 | Upgrade
|
| Gross Profit | 697.56 | 867.42 | 757.68 | 1,544 | 1,458 | Upgrade
|
| Selling, General & Admin | 317.26 | 345.18 | 222.43 | 244.95 | 183.46 | Upgrade
|
| Operating Expenses | 317.26 | 345.18 | 222.43 | 244.95 | 183.46 | Upgrade
|
| Operating Income | 380.3 | 522.25 | 535.25 | 1,299 | 1,274 | Upgrade
|
| Interest Expense | -57.7 | -52.67 | -33.54 | -24.48 | -5.92 | Upgrade
|
| Interest & Investment Income | 2.95 | 10.89 | 17.24 | 15.04 | 2.81 | Upgrade
|
| EBT Excluding Unusual Items | 325.55 | 480.47 | 518.94 | 1,289 | 1,271 | Upgrade
|
| Pretax Income | 325.55 | 480.47 | 518.94 | 1,289 | 1,271 | Upgrade
|
| Income Tax Expense | 39.18 | -1.95 | 103.24 | 255.8 | 254.92 | Upgrade
|
| Earnings From Continuing Operations | 286.37 | 482.42 | 415.7 | 1,034 | 1,016 | Upgrade
|
| Minority Interest in Earnings | 8.77 | 10.62 | 3.97 | -4.45 | -4.36 | Upgrade
|
| Net Income | 295.14 | 493.04 | 419.67 | 1,029 | 1,012 | Upgrade
|
| Net Income to Common | 295.14 | 493.04 | 419.67 | 1,029 | 1,012 | Upgrade
|
| Net Income Growth | -40.14% | 17.48% | -59.22% | 1.71% | 145.33% | Upgrade
|
| Shares Outstanding (Basic) | 293 | 299 | 299 | 299 | 300 | Upgrade
|
| Shares Outstanding (Diluted) | 293 | 299 | 299 | 299 | 300 | Upgrade
|
| Shares Change (YoY) | -2.02% | - | 0.06% | -0.25% | -0.02% | Upgrade
|
| EPS (Basic) | 1.01 | 1.65 | 1.40 | 3.44 | 3.37 | Upgrade
|
| EPS (Diluted) | 1.01 | 1.65 | 1.40 | 3.44 | 3.37 | Upgrade
|
| EPS Growth | -38.91% | 17.48% | -59.25% | 1.96% | 145.38% | Upgrade
|
| Free Cash Flow | 409.43 | -77.99 | 190.74 | 571.54 | 527.23 | Upgrade
|
| Free Cash Flow Per Share | 1.40 | -0.26 | 0.64 | 1.91 | 1.76 | Upgrade
|
| Dividend Per Share | 0.600 | 0.700 | 1.200 | 2.500 | 2.700 | Upgrade
|
| Dividend Growth | -14.29% | -41.67% | -52.00% | -7.41% | 170.00% | Upgrade
|
| Gross Margin | 25.18% | 31.37% | 31.90% | 45.52% | 46.40% | Upgrade
|
| Operating Margin | 13.73% | 18.89% | 22.53% | 38.30% | 40.56% | Upgrade
|
| Profit Margin | 10.65% | 17.83% | 17.67% | 30.35% | 32.21% | Upgrade
|
| Free Cash Flow Margin | 14.78% | -2.82% | 8.03% | 16.85% | 16.78% | Upgrade
|
| EBITDA | 563.43 | 678.2 | 680.72 | 1,463 | 1,434 | Upgrade
|
| EBITDA Margin | 20.34% | 24.53% | 28.66% | 43.12% | 45.63% | Upgrade
|
| D&A For EBITDA | 183.13 | 155.96 | 145.47 | 163.59 | 159.33 | Upgrade
|
| EBIT | 380.3 | 522.25 | 535.25 | 1,299 | 1,274 | Upgrade
|
| EBIT Margin | 13.73% | 18.89% | 22.53% | 38.30% | 40.56% | Upgrade
|
| Effective Tax Rate | 12.04% | - | 19.89% | 19.84% | 20.05% | Upgrade
|
| Revenue as Reported | 2,773 | 2,776 | 2,393 | 3,407 | 3,145 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.